The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma

Ítems similars

• Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
  per: Nemiche, O, et al.
  Publicat: (2011)
• Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
  per: Alexeeva, E, et al.
  Publicat: (2011)
• Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
  per: Miyamae, Takako, et al.
  Publicat: (2011)
• Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
  per: Horneff, G, et al.
  Publicat: (2015)
• Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
  per: Kaleda, Maria I, et al.
  Publicat: (2014)